Business Wire

Paris Hilton Returns as the Face of KARL LAGERFELD as NOT-KARL Debuts for Fall–Winter 2026

1.9.2026 08:30:00 CEST | Business Wire | Press release

Share

Following the success of the Maison's Fall-Winter 2025 and Spring-Summer 2026 campaigns, KARL LAGERFELD is delighted to announce the extension of its relationship with global entrepreneur, media personality and cultural icon Paris Hilton, continuing a partnership that has resonated with audiences around the world.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260831566835/en/

KARL LAGERFELD - Paris Hilton ©Matt Easton

As the face of the Maison through Fall-Winter 2026 and Spring-Summer 2027, Paris Hilton returns for the next chapter of KARL LAGERFELD's From Paris With Love story, continuing to bring her signature confidence, wit and individuality. Photographed for the first time by Matt Easton, the Fall-Winter 2026 campaign introduces a new dimension to the narrative while remaining true to the House's established codes.

At the heart of the Fall-Winter 2026 story, two masters of self-reinvention meet. Making his debut is NOT-KARL, a charismatic digital character and new member in the brand’s world. Appearing alongside Paris Hilton, he brings a fresh dimension to the storytelling. Set against a series of retro multi-screen televisions, he appears throughout the campaign with Paris, bringing contrast, humor and playful irreverence to the narrative - marking the first step in NOT-KARL’s broader story beyond this season.

“Paris has brought energy, authenticity and a strong sense of individuality to our campaigns over the past two seasons,” says Pier Paolo Righi, CEO of Karl Lagerfeld. “Continuing that relationship while introducing NOT-KARL feels particularly meaningful. As a new member of the brand’s world, he brings wit and irreverence, creating an unexpected dialogue with Paris and giving us new and innovative ways to play with format, storytelling and perspective while remaining true to Karl’s point of view.”

Together, Paris Hilton and NOT-KARL form an unexpected on-screen duo, their contrasting personalities creating a playful dynamic throughout the campaign. Their exchanges create a sense of spontaneity within the story, while reinforcing the campaign’s central themes of individuality and self-reinvention.

“Continuing the relationship feels incredibly special,” says Paris Hilton. “Every campaign has felt like its own moment, and I love that we keep finding new ways to bring our worlds together. Having NOT-KARL on set made this shoot feel so iconic and just unexpected — it brought such a magical energy. I’m excited for what’s to come next!”

This season, Paris is joined by Kit Butler as the face of menswear. With his understated confidence and strong fashion profile, Kit is a contemporary counterpart to Paris, and their long-standing friendship lends effortless chemistry.

There are also two special cameo appearances to watch out for, adding a playful note to the story.

The Fall-Winter 2026 collection brings together sharp tailoring, elevated outerwear and the graphic simplicity that defines the House. Rendered in a predominantly monochromatic palette, the collection balances strong silhouettes with refined details, from a long white shirt inspired by tuxedo dressing to the K/Autograph bag range, one of the season's defining accessories.

The Fall-Winter 2026 campaign will launch globally across digital, social, print and out-of-home platforms beginning September 1st, 2026, bringing together the KARL LAGERFELD, KARL LAGERFELD JEANS and KARL LAGERFELD PARIS collections under a single creative narrative.

The campaign will be celebrated during Paris Fashion Week with a special event hosted by the Maison. Further details will be announced early September.

ABOUT KARL LAGERFELD

The House of KARL LAGERFELD shares the iconic vision and design aesthetic of its founder, Karl Lagerfeld, fused with a contemporary, forward-looking spirit. The brand celebrates his colossal legacy and breathes his passion, intuition, and inexhaustible creativity into the core of its DNA.

Featuring Parisian-inspired classics with a rock-chic attitude, the brand portfolio includes ready-to-wear for women, men and kids, plus KARL LAGERFELD JEANS, bags, small leather goods, footwear, fragrances and eyewear. Additional categories include the KARL LAGERFELD MAISON furniture collection and international hospitality projects. The Maison’s creative vision is led by Creative Director Hun Kim; other members of the KARL family are Brand Ambassador Sebastien Jondeau, and Impact Ambassador Amber Valletta, amongst others.

KARL LAGERFELD connects with consumers at more than 200 stores worldwide — including premium wholesale and franchise partners — with key locations in Paris, London, Munich, Dubai and Shanghai. The brand has a robust digital presence across Europe, the Middle East, Asia, and its KARL.COM flagship.

In 2019, KARL LAGERFELD joined the Fashion Pact, a global sustainability initiative seeking to transform the fashion industry through objectives in three areas: climate, biodiversity and ocean protection.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260831566835/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Enhertu® Plus Pertuzumab Approved in the EU as First New Regimen in More than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer1.9.2026 08:30:00 CEST | Press release

Approval based on DESTINY-Breast09 phase 3 trial results that showed Daiichi Sankyo and AstraZeneca’s Enhertu plus pertuzumab reduced the risk of disease progression or death by 44% versus THP with a median progression-free survival exceeding three years Second approval for Enhertu in the EU in two months Enhertu® (trastuzumab deruxtecan) in combination with pertuzumab has been approved in the European Union (EU) for the first-line treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+ or in-situ hybridization [ISH]+) breast cancer. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results fro

Flashnet Partners with Netmore in Strategic Global Partnership for Smart Street Lighting1.9.2026 08:00:00 CEST | Press release

Collaboration combines carrier-grade LoRaWAN® connectivity with award-winning smart street lighting technology to accelerate smart city transformation Netmore Group, the leading network operator and platform provider for Massive IoT, today announced that Flashnet, a Lucy Group company and global leader in intelligent street lighting solutions, has joined Netmore's Pulse Partner Program. The partnership marks another important milestone in Netmore's growing ecosystem, combining best-in-class connectivity with proven smart infrastructure solutions to accelerate the digital transformation of cities and utilities around the world. Driven by rapid urbanisation, government sustainability mandates, and the accelerating rollout of smart city programs worldwide, smart street lighting is increasingly recognized as the entry point for smart city transformation and one of the fastest-growing segments of the global IoT infrastructure market. As municipalities and utilities continue to modernize cri

Fujirebio Expands Access in Canada to Blood-based Neurology Testing with Health Canada Class II Medical Device Licenses for the Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma Assays1.9.2026 07:00:00 CEST | Press release

H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Health Canada has issued Class II Medical Device Licenses (MDL) for the Lumipulse G NfL Blood and the Lumipulse G pTau 217 Plasma assay for use on the fully automated LUMIPULSE® G immunoassay platform in the Canadian market. "The approval of the Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma assays for clinical use in Canada marks another important step in our mission to expand access to reliable and clinically meaningful blood-based biomarkers for clinicians and patients worldwide," said Christiaan De Wilde, CEO of Fujirebio Europe N.V. “As a pioneer in neurological diagnostics, Fujirebio remains committed to advancing patient care through innovative, fully automated testing solutions." These approvals further strengthen Fujirebio’s comprehensive neurological diagnostics portfolio by broadening access to high-quality biomarker solutions designed to inform clinical decision-making across the

Helical Fusion Named a Final Candidate for Japan’s METI Fusion Power Demonstration Program1.9.2026 04:00:00 CEST | Press release

Milestone-based government program supports multiple fusion approaches toward power demonstration and commercialization Helical Fusion Co., Ltd., a fusion energy company developing a Helical Stellarator toward commercially viable fusion power, has been named a final candidate for Japan’s Ministry of Economy, Trade and Industry (METI) program supporting the demonstration of fusion power generation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260831991676/en/ Image of Helix HARUKA, Helical Fusion’s Integrated Demo Device(left), and Helix KANATA, Helical Fusion’s Fusion Pilot Plant(right) The program is designed to accelerate fusion power demonstration in the 2030s under Japan’s national energy and fusion strategies. It supports private-sector technology development across multiple fusion approaches, including tokamak, stellarator and laser fusion, with approximately JPY 60 billion in total government support anticipated ove

Strategic Combination of ITC Infotech and Happiest Minds Technologies to Create a Scaled, Future-Ready, AI-First Global Technology Services Enterprise with US$ 1 Billion Revenue by FY28[1]31.8.2026 23:35:00 CEST | Press release

ITC Infotech Board approves proposed acquisition of 22.1% promoter stake and a Scheme of Amalgamation of the two companies ITC Infotech (ITCI), a wholly owned subsidiary of ITC Limited and a leading global technology services player, today announced the proposed strategic combination with Happiest Minds Technologies Limited (Happiest Minds) to create a scaled, future-ready, AI-first global technology services enterprise. The ITCI Board approved a proposal to acquire 22.1% equity stake from the promoter of Happiest Minds in two tranches under a Share Purchase Agreement. The transaction would be funded through a Rights Issue by ITC Infotech. ITCI Board has also approved a proposed Scheme of Amalgamation of Happiest Minds with ITCI which will be effected after the share acquisition. Pursuant to the scheme, the shares of ITCI will be listed on the stock exchanges. The proposed transaction has also been endorsed by the Board of Directors of ITC Limited. This strategic combination will syner

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye